Appropriate prescribing in older people

Reviews in Clinical Gerontology

Volumn 24, Issue 1, 2014, Pages 58-77

  Penge, Justin ^a   Crome, Peter ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

adverse drug events; appropriate prescribing; older people; polypharmacy; prescribing indicators

Indexed keywords

ARTICLE; CLINICAL RESEARCH; HEALTH EDUCATION; HUMAN; INAPPROPRIATE PRESCRIBING; INFORMATION TECHNOLOGY; INTERPERSONAL COMMUNICATION; MEDICATION COMPLIANCE; POLYPHARMACY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TERMINAL CARE; TREATMENT RESPONSE;

EID: 84891742528     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259813000221     Document Type: Article

References (121)

1. Gurwitz JH, Field TS, Avorn J et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94.
2. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200-9. (Pubitemid 32207229)
3. Prescriptions Dispensed in the Community: Statistics for 2001 to 2011, England. Available at: https://catalogue.ic.nhs.uk/publications/prescribing/ primary/pres-disp-com-eng-2001-11/pres-disp-com-eng-2001-11-rep.pdf
4. Habicht DW, Witham MD, McMurdo MET. The under-representation of older people in clinical trials: Barriers and potential solutions. J Nutr Health Aging 2008; 12: 194-96. (Pubitemid 351450117)
5. Gu Q, Dillon CF, Burt VL. Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007-2008. CDC. National Center for Health Statistics Data Brief No. 42, September 2010. Available at: http://www.cdc.gov/ nchs/data/databriefs/db42.pdf
6. Department of Health. National Service Framework for Older People. Annual Report. London: HMSO; 2007.
7. Merten H, Zegers M, de Bruijne MC, Wagner C. Scale, nature, preventability and causes of adverse events in hospitalised older patients. Age Ageing 2013; 42: 87-93.
8. Committee on Quality in Healthcare in America, Institute of Medicine. To Err Is Human: Building a safer health system. Kohn LT, Corrigan JM, Donaldson MS (eds). Washington DC: National Academy Press; 2000.
9. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57: 121-26.
10. Franceschi M, Scarcelli C, Niro V et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008; 31: 545-56. (Pubitemid 351693687)
11. Mukhopadhyay I, Lally F, Crome P. Appropriate prescribing in older people. Rev Clin Gerontol 2007; 17: 139-51. (Pubitemid 351729440)
12. Parish PA. Drug prescribing-the concern of all. R SocHealth J 1973; 93: 213-17.
13. Somel M, Khaitovich P, Bahn S, Paabo S, Lachmann M. Gene-expression becomes heterogenous with age. Curr Biol 2006; 16: R359-60.
14. Nelson EA, Dannefer D. Aged heterogeneity: fact or fiction The fate of diversity in gerontological research. Gerontologist 1992; 32: 17-23.
15. Department of Health. National Service Framework for Older People. Medicines and Older People. London: HMSO; 2001.
16. Jackson SHD, Mangoni AA, Batty GM. Optimization of drug prescribing. Br J Clin Pharmacol 2004; 57: 231-36. (Pubitemid 38296985)
17. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatric Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc 2012; 60: 616-31.
18. Barber N. What constitutes good prescribing BMJ 1995; 310: 923-25.
19. Joosten EAG, DeFuentes-Merillas L, de Weert GH, Sensky T, van der Staak CPF, de Jong CAJ. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychother Psychosom 2008; 77: 219-26. (Pubitemid 351685446)
20. Nascher IL. Geriatrics. NY Med J 1909; 358-59.
21. Lewis JH, Kilgore ML, Goldman DP et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003; 21: 1383-89. (Pubitemid 46606420)
22. Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341: 2061-67. (Pubitemid 30035956)
23. Ford JG, Howerton MW, Lai GY et al. Barriers to recruiting underrepresented populations to cancer clinical trials: A systematic review. Cancer 2008; 112: 228-42.
24. Rich MW, Bosner MS, Chung MK, Shen J, McKenzie JP. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction Am J Med 1992; 92: 7-13.
25. Lee PY, Alexander KP, Hammill BG, Pasquali SK, Peterson ED. Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001; 286: 708-13.
26. Masoudi FA, Havranek EP, Wolfe P et al. Most hospitalized older persons do not meet the enrolment criteria for clinical trials in heart failure. Am Heart J 2003; 146: 250-57. (Pubitemid 36951768)
27. Giovanazzi-Bannon S, Rademaker A, Lai G, Benson AB. Treatment tolerance of elderly cancer patients entered on to phase II clinical trials: an Illinois Cancer Center Study. J Clin Oncol 1994; 12: 2447-52. (Pubitemid 24346719)
28. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 2009; 27: 2758-65.
29. Unger JM, Coltman CA, Crowley JJ et al. Impact of the year 2000 Medicare policy change on older patient enrolment to cancer clinical trials. J Clin Oncol 2006; 24: 141-44. (Pubitemid 46630505)
30. The IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-63.
31. Cherubini A, Del Signore S, Ouslander J, Semla T, Michel JP. Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010; 58: 1791-96.
32. Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance-Achieving Partnership in Medicine-taking. London: Royal Pharmaceutical Society of Great Britain; 1987.
33. Royal College of Physicians. National Clinical Sentinel Audit of Evidence-based Prescribing for Older People. London: Royal College of Physicians; 2000.
34. Thomson S, Crome P. Appropriate prescribing in older people. Rev Clin Gerontol 2002; 12: 213-20. (Pubitemid 36383272)
35. Kairuz T, Bye L, Birdsall R et al. Identifying compliance issues with prescription medicines among older people: a pilot study. Drugs Aging 2008; 25: 153-62. (Pubitemid 351225819)
36. Burns E, Austin CA, Bax NDS. Elderly patients' understanding of their drug therapy: the effect of cognitive function. Age Ageing 1990; 19: 236-40. (Pubitemid 20380631)
37. Nunney J, Raynor DK, Knapp P, Closs SJ. How do the attitudes and beliefs of older people and healthcare professionals impact on the use of multi-compartment compliance aids Drugs Aging 2011; 28: 403-14.
38. Donovan JL. Patient decision making: the missing ingredient in compliance research. Int J Tech Assess Health Care 1995; 11: 443-55.
39. World Health Organisation. International drug monitoring: the role of the hospital. World Health Organ Tech Rep Ser 1969; 425: 5-24.
40. Chin MH, Wang LC, Jin L et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6: 1232-41.
41. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294-300.
42. Beers MH, Ouslander JG, Fingold SF et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med 1992; 117: 684-89.
43. Beers MH, Ouslander JG, Rollinger I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151: 1825-32.
44. Opondo D, Eslami S, Visscher S, de Rooij SE, Verheij R et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS ONE 2012; 7: e43617.doi:10.1371/ journal.pone.0043617
45. Goulding MR. Inappropriate medication prescribing for elderly ambulatory-care patients. Arch Intern Med 2004; 164: 305-12. (Pubitemid 38176470)
46. Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994; 154: 2195-200. (Pubitemid 24317266)
47. Zhan C, Sangl J, Bierman AS et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286: 2823-29. (Pubitemid 33126924)
48. Giron MS, Wang HX, Bernsten C, Thorslund M, Winblad B, Fastbom J. The appropriateness of drug use in an older non-demented and demented population. J Am Geriatr Soc 2001; 49: 277-83. (Pubitemid 32240294)
49. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-79.
50. Boyd CM, Darer J, Boult C, Frier LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA 2005; 294: 716-24. (Pubitemid 41159291)
51. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797-803. (Pubitemid 34517406)
52. Naughton C, Bennett K, Feely J. Prevalence of chronic disease in the elderly based on a national pharmacy claims database. Age Ageing 2006; 35: 633-36. (Pubitemid 44614162)
53. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older patients. Arch Intern Med 2010; 170: 1648-54.
54. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997; 315: 1096-99. (Pubitemid 27458409)
55. Harris CM, Dajda R. The scale of repeat prescribing. Br J Gen Pract 1996; 46: 649-53. (Pubitemid 26388408)
56. Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20: 817-32. (Pubitemid 37159599)
57. Schwartz RK, Soumerai SB, Avorn J. Physician motivations for non-scientific drug prescribing. Soc Sci Med 1989; 28: 577-82. (Pubitemid 19058005)
58. Zarba A, Storr CL, Wagner FA. Carrying habits into old age: prescription drug use without medical advice by older American adults. J Am Geriatr Soc 2005; 53: 170-71. (Pubitemid 41647655)
59. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine 2010; 89: 295-99.
60. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-51.
61. Barry PJ, Gallagher P, Ryan C, O'Mahony D. START (Screening Tool to Alert doctors to Right Treatment)-an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007; 36: 632-38. (Pubitemid 350258972)
62. Wei JY. Disorder of the heart. In Hazzard WR, Beirman EL, Blass JP (eds). Principles of Geriatric Medicine and Gerontology, 3rd edn, pp. 517-32. New York: McGraw-Hill; 1994.
63. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 1997: 277: 115-21. (Pubitemid 27030178)
64. Chin MH, Wang JC, Zhang JX, Lang RM. Utilization and dosing of angiotensin-converting enzyme inhibitors for heart failure. J Gen Intern Med 1997; 12: 563-66.
65. Croft JB, Giles WH, Roegner RH, Anda RF, Casper ML, Livengood JR. Pharmacologic management of heart failure among older adults by office-based physicians in the United States. J Fam Pract 1997; 44: 382-90. (Pubitemid 27174899)
66. Mendelson G, Aronow WS. Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J Am Geriatr Soc 1998; 46: 751-52.
67. Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29: 463-75.
68. Kuijpers MAJ, van Marum RJ, Egberts ACG, Jansen PAF. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130-33. (Pubitemid 350265160)
69. Medication for Older People. Report of a working party of the Royal College of Physicians, 2nd edn, 1997.
70. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-36. (Pubitemid 27305197)
71. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163: 2716-24. (Pubitemid 37517412)
72. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83. (Pubitemid 351233792)
73. Hamilton H, Gallagher P, Ryan C, Byrne S, O'Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013-19.
74. Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010; 107: 543-51.
75. McLeod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997; 156: 385-91. (Pubitemid 27078035)
76. Naugler CT, Brymer C, Stolee P, Arcese ZA. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000; 7: 103-7.
77. Hanlon JT, Schmader KE, Samsa GP et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-51.
78. Wenger NS, Shekelle PG. Assessing care of vulnerable elders: ACOVE Project Overview. Ann Intern Med 2001; 135: 642-46. (Pubitemid 33015477)
79. Tully MP, Cantrill JA. The validity of explicit indicators of prescribing appropriateness. Int J Qual Health Care 2006; 18: 87-94.
80. Onder G, Landi F, Liperoti R, Fialova D, Gambassi G, Bernabei R. Impact of appropriate drug use among hospitalized older adults. Eur J Clin Pharmacol 2005; 61: 453-59. (Pubitemid 41569324)
81. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly Br J Clin Pharmacol 2007; 63: 177-86. (Pubitemid 46072104)
82. Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755-65. (Pubitemid 351664440)
83. Spinewine A, Swine C, Dhillon S et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007; 55: 658-65. (Pubitemid 46668957)
84. Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725-31. (Pubitemid 47052052)
85. Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med 2001; 135: 703-10. (Pubitemid 33015483)
86. Wenger NS, Roth CP, Shekelle P, ACOVE Investigators. Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc 2007; 55 (suppl 2): S247-52. (Pubitemid 47512132)
87. Fitzgerald LS, Hanlon JT, Shelton PS et al. Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother 1997; 31: 543-48. (Pubitemid 27203949)
88. Kassam R, Martin LG, Farris KB. Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003; 37: 40-46. (Pubitemid 36068596)
89. Cantrill JA, Sibbald B, Buetow S. Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility and reliability. Qual Saf Health Care 1998; 7: 130-35.
90. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007; 9: 430-34. (Pubitemid 46979143)
91. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 2010; 170: 1648-54.
92. Buetow SA, Sibbald B, Cantrill JA, Halliwell S. Appropriateness in health care: application to prescribing. Soc Sci Med 1997; 45: 261-71. (Pubitemid 27270375)
93. Oborne CA, Batty GM, Maskrey V, Swift CG, Jackson SH. Development of prescribing indicators for elderly medical inpatients. Br J Clin Pharmacol 1997; 43: 91-97. (Pubitemid 27060276)
94. Grant RL, Batty GM, Aggarwal R et al. National sentinel clinical audit of evidence-based prescribing for older people: methodology and development. J Eval Clin Pract 2002; 8: 189-98. (Pubitemid 34685895)
95. O'Mahony D, O'Connor MN. Pharmacotherapy at the end-of-life. Age Ageing 2011; 40: 419-22.
96. Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care 2011; 19: 15-21.
97. Hardy JE, Hilmer SN. Deprescribing in the last year of life. J Pharm Pract Res 2011; 41: 146-51.
98. Currow DC, Stevenson JP, Abernethy AP, Plummer J, Shelby-James TM. Prescribing in palliative care as death approaches. J Am Geriatr Soc 2007; 55: 590-95. (Pubitemid 46496589)
99. Faull C, Windridge K, Ockleford E, Hudson M. Anticipatory prescribing in terminal care at home: what challenges do community health professionals encounter BMJ Support Palliat Care 2013; 3: 91-97.
100. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006; 54: 1516-23. (Pubitemid 44564145)
101. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication-use in vulnerable elders. J Am Geriatr Soc 2007; 55: S373-82. (Pubitemid 47515348)
102. Basra R, Kelleher C. A review of solifenacin in the treatment of urinary incontinence. Ther Clin Risk Manag 2008; 4: 117-28. (Pubitemid 351460937)
103. Hesch K. Agents for treatment of overactive bladder: a therapeutic class review. Proc (Bayl Univ Med Cent) 2007; 20: 307-14.
104. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-12.
105. Ansell J, Hirsh J, Hylek E, Jacobsen A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edn). Chest 2008;133 (suppl 6): 160-98S.
106. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657-65. (Pubitemid 36752868)
107. De Vries T, Henning R, Hogerzeil H, Fresle D. Guide to Good Prescribing. A Practical Manual. Geneva: World Health Organisation; 2000.
108. Crotty M, Halbert J, Rowett D et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004; 33: 612-17. (Pubitemid 39504296)
109. Wu JYF, Leung WYS, Chang S et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006; 333: 522-28.
110. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA 1998; 280: 1249-52. (Pubitemid 28469231)
111. Teich JM, Merchia PR, Schmitz JL, Kuperman GJ, Spurr CD, Bates DW. Effects of computerized physician order entry on prescribing practices. Arch Intern Med 2000; 160: 2741-47.
112. Bates DW, Leape LL, Cullen DJ et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 1998; 280: 1311-16. (Pubitemid 28473716)
113. Bates DW. Using information technology to reduce rates of medication errors in hospitals. BMJ 2000; 320: 788-91. (Pubitemid 30179435)
114. Kuperman GJ, Bobb A, Payne TH et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14: 29-40. (Pubitemid 44909484)
115. Haffey F, Brady RRW, Maxwell S. Smartphone apps to support hospital prescribing and pharmacology education: a review of current provision. Br J Clin Pharmacol 2013; doi: 10.1111/bcp.12112 116.
116. Charani E, Kyratsis Y, Lawson W et al. An analysis of the development and implementation of a smartphone application for the delivery of antimicrobial prescribing policy: lessons learnt. J Antimicrob Chemother 2013; 68: 960-67.
117. Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC. Smartphone medication adherence apps: potential benefits to patients and providers. J Am Pharm Assoc 2013; 53: 172-81.
118. Haffey F, Brady RRW, Maxwell S. A comparison of the reliability of smartphone apps for opioid conversion. Drug Safety 2013; 36: 111-17.
119. Hume AL, Quilliam BJ, Goldman R, Eaton C, Lapane KL. Alternatives to potentially inappropriate medications for use in e-prescribing software: triggers and treatment algorithms. BMJ Qual Saf 2011; 20: 875-84.
120. European Commission Seventh Framework Programme. SENATOR Project: Development and clinical trials of a new Software ENgine for the Assessment & Optomisation of drug and non-drug Therapy in Older peRsons. Available at: http://ec.europa.eu/research/health/medicalresearch/human-development-andageing/ projects/senator-en.html (accessed 30 June 2013).
121. Merten H, Zegers M, de Bruijne MC, Wagner C. Scale, nature, preventability and causes of adverse events in hospitalised older patients. Age Ageing 2013; 42: 87-93.